Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Surgical Oncology Clinics of North America|November 13, 2025
Precision Oncology in Pancreatic Cancer and Future Treatment DirectionsLayal Al Mahmasani, Eileen M O'ReillyClinical Medicine Insights. Case Reports|October 24, 2022
Tumor Lysis Syndrome: A Rare Complication of Metastatic Gastric Cancer and a Possible Indicator of Disease ProgressionSalim Barakat, Batoul Abdallah, Antoine Finianos, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 10, 2023
Colorectal Cancer Screening in the Middle East: What, Why, Who, When, and How?Ali Shamseddine, Laudy Chehade, Layal Al Mahmasani, et al.Hematology/Oncology Clinics of North America|February 29, 2024
Immunotherapy: A Sharp Curve Turn at the Corner of Targeted Therapy in the Treatment of Biliary Tract CancersLayal Al Mahmasani, James J Harding, Ghassan Abou-AlfaFrontiers in Immunology|June 8, 2026
Organ-specific pre-metastatic and metastatic niches in colorectal cancer: "discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis"Mohamad Mourad, Layal Al Mahmasani, Noura Abbas, et al.Current Oncology Reports|August 4, 2026
Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided StrategiesLayal Al Mahmasani, Mohamad Mourad, Noura Abbas, et al.Annals of Hematology|February 2, 2021
COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implicationsLayal Al Mahmasani, Mohammad Hassan Hodroj, Antoine Finianos, et al.International Journal of Molecular Sciences|April 14, 2026
EGFR Signaling in Colorectal Cancer: Novel Therapeutic Strategies, Predictive Biomarkers, and Counteracting Treatment ResistanceNoura Abbas, Mohamad Mourad, Hiba Smaily, et al.Frontiers in Oncology|November 3, 2023
Preferences for the sequencing of first-line systemic treatments in metastatic hormone receptor-positive, HER2-negative breast cancerLayal Al Mahmasani, Ghid Amhaz, Reine Abou Zeidane, et al.Nuclear Medicine Communications|March 10, 2023
Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart reviewMohamad Haidar, Layal Al Mahmasani, Laudy Chehade, et al.Pageof 2